The position was initially added as a hedge against our long Galenica position (currently up 31% since inception).
from Peter Garnry - Authored content https://www.tradingfloor.com/posts/saxostratsupdate-closing-our-novartis-short-with-small-14-profit-6604748?utm_medium=tf4-feed&utm_source=extract
via IFTTT
#SaxoStrats.UPDATE: Closing our Novartis short with small 1.4% profit
ad
Enregistrer un commentaire